Get in Touch

LIGHT LINE MEDICAL, INC. TO PRESENT AT BIOTECH SHOWCASE™ 2020 IN SAN FRANCISCO

Photo-disinfection. No drugs, no chemicals, no UV.
Key Takeaways
  • Light Line Medical, Inc.’s patented Photo-disinfection™ technology is the first commercial application of Antimicrobial Blue Light Therapy (aBLT) in catheters.
  • Without drugs, chemicals, or UV light, Photo-disinfection eliminates both intraluminal and extraluminal microbes, drastically reducing the risk of antibiotic resistance.
  • Light Line Medical has proven Photo-disinfection’s efficacy, secured a robust IP portfolio, recruited an experienced management team, secured strategic investment and a distribution agreement with the largest private distributor of medical devices in North America.


Salt Lake City, Utah/Jan. 8, 2020 – Light Line MedicalTM, Inc. today announced that it has been invited to present at Biotech Showcase™ 2020, to be held January 13–15, during the most important week in healthcare at the Hilton San Francisco Union Square.

Vicki Farrar, CEO, will be presenting the LightLine Photo-disinfectionTM technology at Biotech Showcase as follows:

Date: Tuesday, January 14, 2020

Time: 2:00 PM (PST)

Room: Franciscan B

Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, CA (United States)

Ms. Farrar will be available to participate in one-on-one meetings with members of the investment community.

Light Line Medical’s patented Photo-disinfection™ technology is the first commercial application of Antimicrobial Blue Light Therapy (aBLT) in catheters. Photo-disinfection is a ground-breaking way to fight catheter associated infections (CAIs), one of the most common infections affecting millions of people every year, deepening the world’s antimicrobial resistance epidemic. Without drugs, chemicals, or UV light, Photo-disinfection eliminates both intraluminal and extraluminal microbes, drastically reducing the risk of antibiotic resistance. Further, Photo-disinfection prevents CAIs in every urinary and dialysis catheter we’ve tested, and we expect full effectiveness in respiratory and vascular catheters as well. First to market are the dialysis and urinary systems, with initial product launch expected June 2021.

 “Photo-disinfection is our best option for eliminating CAIs and helping avert the global antimicrobial resistance crises. It’s going to cause a significant decline in global catheter-related infection rates, and all of us remain excited at the prospect of preventing infections, rather than treating them.” says Vicki Farrar, CEO of Light Line Medical. 

ABOUT LIGHT LINE MEDICAL

Light Line Medical, Inc. is based in Salt Lake City, UT. We are introducing Photo-disinfection™ of catheters to the world, which will help reduce the world’s antibiotic resistance crisis. We have proven Photo-disinfection’s efficacy, secured a robust IP portfolio protecting the technology, recruited an experienced management team, secured strategic investment, and have a distribution agreement with the largest private distributor of medical devices in North America. For more information and investment opportunity contact Vicki Farrar and visit www.lightlinemedical.com.

Contacts

Vicki Farrar

CEO

(435)729-9397

farrar@lightlinemedical.com

ABOUT BIOTECH SHOWCASE

Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather in San Francisco during this bellwether week which sets the tone for the coming year. Now in its 12th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.

Key Takeaways
  • Light Line Medical, Inc.’s patented Photo-disinfection™ technology is the first commercial application of Antimicrobial Blue Light Therapy (aBLT) in catheters.
  • Without drugs, chemicals, or UV light, Photo-disinfection eliminates both intraluminal and extraluminal microbes, drastically reducing the risk of antibiotic resistance.
  • Light Line Medical has proven Photo-disinfection’s efficacy, secured a robust IP portfolio, recruited an experienced management team, secured strategic investment and a distribution agreement with the largest private distributor of medical devices in North America.
Media Gallery
Contacts
Vicki Farrar (CEO)
farrar@lightlinemedical.com
(435)729-9397